Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical care, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is headquartered in Columbus, Georgia.
IPO Year:
Exchange: NYSE
Website: aflac.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/23/2025 | $111.00 | Market Perform | BMO Capital Markets |
| 10/9/2024 | $102.00 | Hold | TD Cowen |
| 9/5/2024 | $96.00 | Underweight | Barclays |
| 1/4/2024 | $76.00 → $78.00 | In-line → Underperform | Evercore ISI |
| 8/18/2023 | $74.00 → $75.00 | Overweight → Equal-Weight | Morgan Stanley |
| 6/5/2023 | $77.00 | Buy | BofA Securities |
| 4/25/2023 | $73.00 | Equal Weight | Wells Fargo |
| 5/24/2022 | $60.00 | Neutral | Citigroup |
| 2/22/2022 | $67.00 → $69.00 | Overweight | Morgan Stanley |
| 2/7/2022 | $60.00 → $67.00 | Outperform | Raymond James |